Long Non-Coding RNA HOXA11-AS Modulates Proliferation, Apoptosis, Metastasis and EMT in Cutaneous Melanoma Cells Partly via miR-152-3p/ITGA9 Axis

References

• Slominski A, Tobin DJ, Shibahara S, Wortsman J. Melanin pigmentation in mammalian skin and its hormonal regulation. Physiol Rev. 2004;84(4):1155–1228. doi:10.1152/physrev.00044.200315383650
   PubMed Web of Science ®Google Scholar
• Gray-Schopfer V, Wellbrock C, Marais R. Melanoma biology and new targeted therapy. Nature. 2007;445(7130):851–857. doi:10.1038/nature0566117314971
   PubMed Web of Science ®Google Scholar
• Slominski AT, Zmijewski MA, Plonka PM, Szaflarski JP, Paus R. How UV light touches the brain and endocrine system through skin, and why. Endocrinology. 2018;159(5):1992–2007. doi:10.1210/en.2017-0323029546369
   PubMed Web of Science ®Google Scholar
• Smith SH, Goldschmidt MH, McManus PM. A comparative review of melanocytic neoplasms. Vet Pathol. 2002;39(6):651–678. doi:10.1354/vp.39-6-65112450197
   PubMed Web of Science ®Google Scholar
• O’Day S, Boasberg P. Management of metastatic melanoma 2005. Surg Oncol Clin N Am. 2006;15(2):419–437. doi:10.1016/j.soc.2005.12.00216632224
   PubMed Web of Science ®Google Scholar
• Abate-Daga D, Ramello MC, Smalley I, Forsyth PA, Smalley KSM. The biology and therapeutic management of melanoma brain metastases. Biochem Pharmacol. 2018;153:35–45. doi:10.1016/j.bcp.2017.12.01929278675
   PubMed Web of Science ®Google Scholar
• Little EG, Eide MJ. Update on the current state of melanoma incidence. Dermatol Clin. 2012;30(3):355–361. doi:10.1016/j.det.2012.04.00122800543
   PubMed Web of Science ®Google Scholar
• Hsiao JJ, Fisher DE. The roles of microphthalmia-associated transcription factor and pigmentation in melanoma. Arch Biochem Biophys. 2014;563:28–34. doi:10.1016/j.abb.2014.07.01925111671
   PubMed Web of Science ®Google Scholar
• Slominski A, Zbytek B, Slominski R. Inhibitors of melanogenesis increase toxicity of cyclophosphamide and lymphocytes against melanoma cells. Int J Cancer. 2009;124(6):1470–1477. doi:10.1002/ijc.2400519085934
   PubMed Web of Science ®Google Scholar
• Slominski RM, Zmijewski MA, Slominski AT. The role of melanin pigment in melanoma. Exp Dermatol. 2015;24(4):258–259. doi:10.1111/exd.1261825496715
   PubMed Web of Science ®Google Scholar
• Aftab MN, Dinger ME, Perera RJ. The role of microRNAs and long non-coding RNAs in the pathology, diagnosis, and management of melanoma. Arch Biochem Biophys. 2014;563:60–70. doi:10.1016/j.abb.2014.07.02225065585
   PubMed Web of Science ®Google Scholar
• Martens-Uzunova ES, Bottcher R, Croce CM, Jenster G, Visakorpi T, Calin GA. Long noncoding RNA in prostate, bladder, and kidney cancer. Eur Urol. 2014;65(6):1140–1151. doi:10.1016/j.eururo.2013.12.00324373479
   PubMed Web of Science ®Google Scholar
• Li CH, Chen Y. Insight into the role of long noncoding RNA in cancer development and progression. Int Rev Cell Mol Biol. 2016;326:33–65. doi:10.1016/bs.ircmb.2016.04.00127572126
   PubMed Web of Science ®Google Scholar
• Tian Y, Zhang X, Hao Y, Fang Z, He Y. Potential roles of abnormally expressed long noncoding RNA UCA1 and Malat-1 in metastasis of melanoma. Melanoma Res. 2014;24(4):335–341. doi:10.1097/CMR.000000000000008024892958
   PubMed Web of Science ®Google Scholar
• Zhang Y, Qian W, Feng F, et al. Upregulated lncRNA CASC2 may inhibit malignant melanoma development through regulating miR-18a-5p/RUNX1. Oncol Res. 2019;27(3):371–377. doi:10.3727/096504018X1517874072936729422114
   PubMed Web of Science ®Google Scholar
• Lu CW, Zhou DD, Xie T, et al. HOXA11 antisense long noncoding RNA (HOXA11-AS): a promising lncRNA in human cancers. Cancer Med. 2018;7(8):3792–3799. doi:10.1002/cam4.157129992790
   PubMed Web of Science ®Google Scholar
• Lagos-Quintana M, Rauhut R, Lendeckel W, Tuschl T. Identification of novel genes coding for small expressed RNAs. Science. 2001;294(5543):853–858. doi:10.1126/science.106492111679670
   PubMed Web of Science ®Google Scholar
• Cho WC. OncomiRs: the discovery and progress of microRNAs in cancers. Mol Cancer. 2007;6:60. doi:10.1186/1476-4598-6-6017894887
   PubMed Web of Science ®Google Scholar
• Ross CL, Kaushik S, Valdes-Rodriguez R, Anvekar R. MicroRNAs in cutaneous melanoma: role as diagnostic and prognostic biomarkers. J Cell Physiol. 2018;233(7):5133–5141. doi:10.1002/jcp.2639529226953
   PubMed Web of Science ®Google Scholar
• Saldanha G, Elshaw S, Sachs P, et al. microRNA-10b is a prognostic biomarker for melanoma. Mod Pathol. 2016;29(2):112–121. doi:10.1038/modpathol.2015.14926743475
   PubMed Web of Science ®Google Scholar
• Xiong Y, Liu L, Qiu Y, Liu L. MicroRNA-29a inhibits growth, migration and invasion of melanoma A375 cells in vitro by directly targeting BMI1. Cell Physiol Biochem. 2018;50(1):385–397. doi:10.1159/00049401530286469
   PubMedGoogle Scholar
• Palmer EL, Ruegg C, Ferrando R, Pytela R, Sheppard D. Sequence and tissue distribution of the integrin alpha 9 subunit, a novel partner of beta 1 that is widely distributed in epithelia and muscle. J Cell Biol. 1993;123(5):1289–1297. doi:10.1083/jcb.123.5.12898245132
   PubMed Web of Science ®Google Scholar
• Mostovich LA, Prudnikova TY, Kondratov AG, et al. Integrin alpha9 (ITGA9) expression and epigenetic silencing in human breast tumors. Cell Adh Migr. 2011;5(5):395–401. doi:10.4161/cam.5.5.1794921975548
   PubMed Web of Science ®Google Scholar
• Senchenko VN, Kisseljova NP, Ivanova TA, et al. Novel tumor suppressor candidates on chromosome 3 revealed by NotI-microarrays in cervical cancer. Epigenetics. 2013;8(4):409–420. doi:10.4161/epi.2423323478628
   PubMed Web of Science ®Google Scholar
• Dmitriev AA, Kashuba VI, Haraldson K, et al. Genetic and epigenetic analysis of non-small cell lung cancer with NotI-microarrays. Epigenetics. 2012;7(5):502–513. doi:10.4161/epi.1980122491060
   PubMed Web of Science ®Google Scholar
• Li W, Jia G, Qu Y, Du Q, Liu B, Liu B. Long non-coding RNA (LncRNA) HOXA11-AS promotes breast cancer invasion and metastasis by regulating epithelial-mesenchymal transition. Med Sci Monit. 2017;23:3393–3403. doi:10.12659/msm.90489228701685
   PubMed Web of Science ®Google Scholar
• Qu L, Jin M, Yang L, et al. Expression of long non-coding RNA HOXA11-AS is correlated with progression of laryngeal squamous cell carcinoma. Am J Transl Res. 2018;10(2):573–580.29511452
   PubMed Web of Science ®Google Scholar
• Yang JX, Liu B, Yang BY, Meng Q, Meng Q. Long non-coding RNA homeobox (HOX) A11-AS promotes malignant progression of glioma by targeting miR-124-3p. Neoplasma. 2018;65(4):505–514. doi:10.4149/neo_2018_170705N46230064227
   PubMed Web of Science ®Google Scholar
• Lu Q, Zhao N, Zha G, Wang H, Tong Q, Xin S. LncRNA HOXA11-AS exerts oncogenic functions by repressing p21 and miR-124 in uveal melanoma. DNA Cell Biol. 2017;36(10):837–844. doi:10.1089/dna.2017.380828749709
   PubMed Web of Science ®Google Scholar
• Sun J, Tian X, Zhang J, et al. Regulation of human glioma cell apoptosis and invasion by miR-152-3p through targeting DNMT1 and regulating NF2: miR-152-3p regulate glioma cell apoptosis and invasion. J Exp Clin Cancer Res. 2017;36(1):100. doi:10.1186/s13046-017-0567-428764788
   PubMed Web of Science ®Google Scholar
• Ramalho-Carvalho J, Goncalves CS, Graca I, et al. A multiplatform approach identifies miR-152-3p as a common epigenetically regulated onco-suppressor in prostate cancer targeting TMEM97. Clin Epigenetics. 2018;10:40. doi:10.1186/s13148-018-0475-229599847
   PubMed Web of Science ®Google Scholar
• Cui Y, Yi L, Zhao JZ, Jiang YG. Long noncoding RNA HOXA11-AS functions as miRNA sponge to promote the glioma tumorigenesis through targeting miR-140-5p. DNA Cell Biol. 2017;36(10):822–828. doi:10.1089/dna.2017.380528832185
   PubMed Web of Science ®Google Scholar
• Zhan M, He K, Xiao J, et al. LncRNA HOXA11-AS promotes hepatocellular carcinoma progression by repressing miR-214-3p. J Cell Mol Med. 2018;22:3758–3767. doi:10.1111/jcmm.13633
   PubMed Web of Science ®Google Scholar
• Han N, Zuo L, Chen H, Zhang C, He P, Yan H. Long non-coding RNA homeobox A11 antisense RNA (HOXA11-AS) promotes retinoblastoma progression via sponging miR-506-3p. Onco Targets Ther. 2019;12:3509–3517. doi:10.2147/OTT.S19540431123409
   PubMed Web of Science ®Google Scholar
• Xu C, He T, Li Z, Liu H, Ding B. Regulation of HOXA11-AS/miR-214-3p/EZH2 axis on the growth, migration and invasion of glioma cells. Biomed Pharmacother. 2017;95:1504–1513. doi:10.1016/j.biopha.2017.08.09728946213
   PubMed Web of Science ®Google Scholar
• Yang FQ, Zhang JQ, Jin JJ, et al. HOXA11-AS promotes the growth and invasion of renal cancer by sponging miR-146b-5p to upregulate MMP16 expression. J Cell Physiol. 2018;233(12):9611–9619. doi:10.1002/jcp.2686429953617
   PubMed Web of Science ®Google Scholar
• Wang S, Zhang S, He Y, Huang X, Hui Y, Tang Y. HOXA11-AS regulates JAK-STAT pathway by miR-15a-3p/STAT3 axis to promote the growth and metastasis in liver cancer. J Cell Biochem. 2019;120(9):15941–15951. doi:10.1002/jcb.2887131099097
   PubMed Web of Science ®Google Scholar
• Zhang Y, Chen WJ, Gan TQ, et al. Clinical significance and effect of lncRNA HOXA11-AS in NSCLC: a study based on bioinformatics, in vitro and in vivo verification. Sci Rep. 2017;7(1):5567. doi:10.1038/s41598-017-05856-228717185
   PubMed Web of Science ®Google Scholar
• Li B, Wang W, Miao S, et al. HOXA11-AS promotes the progression of oral squamous cell carcinoma by targeting the miR-518a-3p/PDK1 axis. Cancer Cell Int. 2019;19:140. doi:10.1186/s12935-019-0838-631139017
   PubMed Web of Science ®Google Scholar